18 June 2026
UAE
Testvox FZCO
Fifth Floor 9WC Dubai Airport Freezone
Meet FDA Cybersecurity Requirements
18 June 2026
12:33 MIN Read time 
BY
Divya Prakash
The medical device industry is currently weathering a massive shift in how products are designed and regulated. For decades, the primary focus was on mechanical safety and clinical efficacy. If the pump delivered the right dose or the monitor showed the correct heart rate, you were in the clear. But today, the FDA views a medical device not just as a clinical tool, but as a node on a network. With the passage of the Food and Drug Omnibus Reform Act (FDORA) and the release of the 2023 final guidance, cybersecurity is no longer a “nice to have” feature. It is a fundamental requirement for market entry.
Meeting these requirements can feel like aiming at a moving target. However, once you strip away the dense regulatory jargon, the FDA’s expectations are actually quite logical. They want to see that you have thought about security from the first line of code to the day the device is decommissioned. This blog will walk you through the practical steps to align your product with these high standards.
Breaking Down FDA’s Cybersecurity Requirements by Device Class
The FDA usually looks at risks when regulating. With cybersecurity the lines between Device Classes are getting fuzzy. There are three device classes: Class I, II and III. The idea is straightforward: if a device has software features and can link to the internet or a local network it is called a Cyber Device as per Section 524B of the FD&C Act.
For Class I devices, which’re typically less risky the paperwork might seem easier but security requirements are still there. A simple diagnostic app on a smartphone that handles data must be protected from unauthorized access.
Class II and Class III devices, like infusion pumps, pacemakers and robotic surgical systems get the examination. These devices have security expectations because they are more critical.
The FDA wants to make sure these devices are secure and work properly. Cyber Devices must meet standards to ensure patient safety.
The FDAs approach helps keep patients from cybersecurity threats.For these devices, the FDA looks for a “Tiered” approach to security. They want to see that the level of protection is proportional to the potential harm that could occur if the device were compromised. If a breach could lead to a multi patient catastrophic event, your encryption, authentication, and logging must be top tier. Regardless of the class, if your device is connected, the FDA expects you to treat cybersecurity as a life critical safety issue.
Must-Have Documents for FDA Cybersecurity Compliance
When a reviewer opens your submission, they are looking for a specific set of documents that prove your “Secure Product Development Framework” (SPDF). If these pieces are missing, your submission will likely be hit with a Refuse to Accept (RTA) designation.
The Software Bill of Materials (SBOM) is perhaps the most critical document. This is a comprehensive, machine readable inventory of every software component in your device, including open source libraries and third party drivers. The FDA needs this to understand your “attack surface.” If a new vulnerability like Log4j is discovered, the SBOM allows both you and the FDA to know instantly if your device is at risk.
Another essential piece is the Cybersecurity Threat Model. This is not just a high level summary; it is a granular analysis of how an attacker might attempt to exploit your device. You need to document potential entry points, the likelihood of an attack, and the specific mitigations you have put in place.
Finally, you must include a Security Risk Management Plan. This document should bridge the gap between traditional safety risks (like a battery overheating) and security risks (like a hacker draining that battery). The FDA expects you to demonstrate that you have evaluated how security failures could impact the clinical functionality of the device.
How to Map Your Existing Security Controls to FDA Expectations
Many companies already have decent security measures in place, but they fail to explain them in a way that satisfies a regulatory reviewer. Mapping your controls is about “translating” your engineering work into the FDA’s preferred language.
Start by looking at the five core functions defined by the NIST Cybersecurity Framework: Identify, Protect, Detect, Respond, and Recover. The FDA’s guidance is heavily influenced by this structure. For example, your use of AES-256 encryption maps directly to “Protect,” while your system logs and anomaly detection map to “Detect.”
When mapping these controls, be specific. Instead of saying “the device uses secure communication,” specify that “the device utilizes TLS 1.3 for all data in transit between the hardware and the cloud server.” You should also provide a traceability matrix. This matrix should show a clear line from a recognized threat, to a specific security requirement, to the design feature that addresses it, and finally to the test report that proves it works. This “loop” of evidence is what builds confidence in the reviewer’s mind.
Quick Wins to Close Cybersecurity Gaps Before Submission
If you are close to your submission date and realize your cybersecurity posture is a bit thin, there are several “quick wins” that can significantly strengthen your application without requiring a total redesign.
First, focus on authentication. If your device still uses “admin/admin” as a default login or lacks a way to force password changes, fix this immediately. Implementing robust user access controls is one of the most effective ways to satisfy the “Protect” pillar of the FDA requirements.
Second, perform a formal vulnerability scan and penetration test. Even if you don’t have time to fix every minor bug, having a third party report that identifies your vulnerabilities shows the FDA that you are being transparent and proactive. If you find “High” or “Critical” vulnerabilities, create a clear remediation plan. The FDA is often more comfortable with a company that acknowledges its flaws and has a plan to fix them than a company that claims to be perfectly secure.
Third, update your labeling. Ensure that the instructions for use (IFU) include a section on cybersecurity for the end user. Tell them how to securely configure the device, what network ports need to be open, and how they will receive security patches. This demonstrates that you are considering the “post market” phase of the device life cycle.
The Importance of the Post-Market Management Plan
The FDA’s oversight doesn’t end when you get your clearance or approval. In fact, the new regulations place a heavy emphasis on what happens after the device is in the hands of patients. You must have a documented process for “Coordinated Vulnerability Disclosure” (CVD).
This means you need a way for security researchers or customers to tell you if they find a bug, and a clear timeline for how you will investigate and patch that bug. If you cannot provide a plan for how you will update devices in the field, the FDA is unlikely to let you onto the market in the first place. This plan should include how you monitor for new threats (like checking the CVE database) and how you will communicate with your user base during a security event.
Why “Security by Design” Saves Time and Money
It is a common misconception that cybersecurity requirements are just another hurdle to slow down innovation. In reality, adopting a “Security by Design” philosophy actually speeds up your path to market.
When you bake security into the initial architecture, you avoid the “patchwork” approach that often leads to system instability and complicated regulatory questions later on. A clean, well architected system is much easier to document and much harder for a reviewer to pick apart.
Furthermore, the cost of fixing a security flaw during the design phase is a fraction of the cost of a post market recall. In the modern regulatory landscape, being “fast” is no longer about cutting corners; it is about doing the work correctly the first time so you don’t have to repeat the submission process.
Conclusion
At the end of the day medical device cybersecurity is about people. It is about patients who rely on insulin pumps to stay alive and doctors who need robots to work properly. When preparing your FDA submission remember that people are using your technology. Your documentation should not just list specs; it should tell the story of how you protect users.
By being open, detailed and proactive you will do more than just meet FDA requirements. You will create a product that people can trust. That will work well over time in a world with more digital technology. Medical device cybersecurity is important, for patients and doctors who use these devices every day. They need to work safely. So when you prepare your FDA submission make sure you focus on the people who use your technology.
18 June 2026
28 April 2026
29 April 2026
ABOUT TESTVOX
Testvox is a software testing company help your product reach its full potential. Get full cycle testing for your mobile and web applications while ensuring all quality assurance standards are met... Read More
100+
Applications
Assured
Assured
5 Star Rating
5 Star Rating
“By participating in our release lifecycle, Testvox's standard QA process has helped us to launch quality products faster.”
Rima Hudaifa
Manager | Cadvil
Manager | Cadvil
